A recent study published in the Journal of Virology suggests that 2′-fucosyllactose (2′FL), a sugar

February 4, 2025 No Comments

Robert F. T. Bucayu, MD, MPHImage Credit: Children’s Hospital of Philadelphia Children with invasive candidiasis,

February 3, 2025 No Comments

Invivyd announced that new in vitro data confirms Pemgarda™ (pemivibart) continues to effectively neutralize the

February 3, 2025 No Comments

On January 30, The Texas Department of State Health Services (DSHS) announced the third and

February 3, 2025 No Comments

Prashant Kumar Image credits: University of Surrey The Caribbean cruise season typically runs from late

February 3, 2025 No Comments

Image credit: ViiV Healthcare On January 31, the European Commission authorized ViiV Healthcare’s cabotegravir (Vocabria),

February 2, 2025 No Comments

Yesterday, Shionogi, a Japanese pharmaceutical company, announced its novel investigational respiratory syncytial virus (RSV) oral

January 31, 2025 No Comments

The V Quinn trial assessed levofloxacin as a preventive treatment for drug-resistant tuberculosis (MDR-TB) in

January 31, 2025 No Comments

The STOP2030 project in northwestern Argentina aims to develop more effective tools for controlling neglected

January 31, 2025 No Comments

Schedule an Appointment

Quick Links